| Literature DB >> 35460396 |
Zhaohui Liu1, Chunlei Li2, Yan Li2, Lili Yu2, Min Qu2.
Abstract
Propofol (Pro) is well known to regulate the asleep-awake-asleep technique. Increasing indication recommends that Pro also has promising properties such as anti-oxidant and anti-inflammation belongings in several disease models. It has been described that Pro has beneficial properties against renal ischemia/reperfusion (rI/R)-mediated acute lung injury (ALI). Nevertheless, pathogenesis underlying the beneficial action of Pro on the remote ALI mediated by rI/R remains unwell unstated. In this research, we displayed that Pro administration remarkably inhibits rI/R-mediated pro-inflammatory cytokines production. Increased levels of oxidative stress were mainly decreased by Pro. Pro administration ameliorated apoptosis-related caspase-3 activation. Furthermore, the levels of crucial necroptosis-associated protein were reduced by Pro. Sirtuin 1 (SIRT1) inhibitor attenuated the aforementioned changes of Pro. In conclusion, these results propose that Pro attenuates rI/R-induced inflammation, oxidative stress, apoptosis, and necroptosis by up-regulation of SIRT1 in rats. Our findings disclose an original pathogenesis underlying the beneficial effect of Pro against rI/R-mediated ALI and reinforce the knowledge that Pro might be a hopeful beneficial agent for the rI/R-mediated ALI.Entities:
Keywords: Acute kidney injury; Acute lung injury; Alveolar macrophages; Apoptosis; Inflammation; Necroptosis; Oxidative stress.; Propofol; Renal ischemia–reperfusion; SIRT1
Year: 2022 PMID: 35460396 DOI: 10.1007/s10753-022-01673-6
Source DB: PubMed Journal: Inflammation ISSN: 0360-3997 Impact factor: 4.657